APT Medical Inc. (SHA: 688617)

China flag China · Delayed Price · Currency is CNY
345.20
+12.40 (3.73%)
Nov 12, 2024, 3:00 PM CST
36.65%
Market Cap 33.46B
Revenue (ttm) 1.96B
Net Income (ttm) 658.82M
Shares Out 96.94M
EPS (ttm) 6.76
PE Ratio 51.05
Forward PE 47.87
Dividend 1.38 (0.40%)
Ex-Dividend Date Jul 26, 2024
Volume 1,758,969
Open 334.00
Previous Close 332.80
Day's Range 330.57 - 351.00
52-Week Range 213.81 - 480.00
Beta -0.41
Analysts n/a
Price Target n/a
Earnings Date Oct 25, 2024

About APT Medical

APT Medical Inc. engages in the research, development, manufacturing, and supply of electrophysiology and vascular interventional medical devices in China. The company offers electrophysiological products comprising mapping catheters, ablation catheters, transseptal needle and sheaths, and steerable sheaths; and interventional cardiology and peripheral intervention products, such as introducer kits, guiding extension catheters, balloon catheters, guiding catheters, microcatheters, guidewires, hydrophilic angiographic catheters, hydrophilic guid... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2002
Employees 2,155
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688617
Full Company Profile

Financial Performance

In 2023, APT Medical's revenue was 1.65 billion, an increase of 35.71% compared to the previous year's 1.22 billion. Earnings were 533.92 million, an increase of 49.13%.

Financial Statements

News

There is no news available yet.